methylene blue has been researched along with Brain Disorders in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.41) | 18.7374 |
1990's | 13 (35.14) | 18.2507 |
2000's | 7 (18.92) | 29.6817 |
2010's | 8 (21.62) | 24.3611 |
2020's | 7 (18.92) | 2.80 |
Authors | Studies |
---|---|
Campino, GA; Chain, G; Kalia, M; Kestenbaum, K; Pappas, L; Sechser-Perl, A; Zaghloul, N | 1 |
Anlar, B; Aydin, B; Günbey, C; Müngen, E; Öz, S; Yaman Bajin, İ | 1 |
Beyoğlu, D; Idle, JR | 1 |
Wu, C; Yang, L; Youngblood, H; Zhang, Q | 1 |
Atay, AA; Demir, ÜF; Malbora, B; Sarbay, H; Yılmaz, G | 1 |
Abahssain, H; Errihani, H; Essangri, H; Fadhil, FZ; Guessous, F; Meddah, B; Moukafih, B; Mrabti, H; Souadka, A | 1 |
Ataseven, E; Göktepe, ŞÖ; Kantar, M | 1 |
Gambhir, HS; Pruthi, S; Shah, S | 1 |
Guo, B; Han, D; Hu, S; Liang, P; Su, C; Tie, X; Yan, X; Zhang, Q; Zhao, N; Zhuo, X; Zong, X | 1 |
Bellien, J; Duflot, T; Filhon, B; Joannidès, R; Lamoureux, F; Marie-Cardine, A; Massy-Guillemant, N; Pereira, T; Verstuyft, C | 1 |
Gharaibeh, EZ; Powers, BC; Salacz, ME; Telfah, M | 1 |
Miri-Aliabad, G | 1 |
Hou, H; Kinoshita, N; Koyama, N; Maeda, M; Maruyama, N; Mori, T; Segawa, T; Tan, J; Town, T | 1 |
HaDuong, JH; Yeo, KK | 1 |
Beri, R; Shord, SS; Sweiss, KI | 1 |
Casler, J; Festic, E; Freeman, WD; Riutort, K; Rowley, M; Shapiro, D | 1 |
Delfiner, J; Fernandez, J; Pollack, A; Pollack, G | 1 |
Fisher, DC; McDonnell, AM; Rybak, I; Wadleigh, M | 1 |
Barennes, H; Boudat, AM; Idle, JR; Nagot, N; Valea, I | 1 |
David, KA; Picus, J | 1 |
Idle, JR; Küpfer, A; Lauterburg, BH; Lerch, S | 1 |
Allison, AC; Feindel, WH | 1 |
Brooks, RG; Gibbons, D; Luft, BJ; McCabe, RE; Remington, JS | 1 |
Aeschlimann, C; Cerny, T; Küpfer, A; Wermuth, B | 1 |
Dreyfus, G; Eftekari, P; Ferrero, JM; Largillier, R; Namer, M | 1 |
Maton, B; Tullen, E; Zulian, GB | 1 |
Demandt, M; Wandt, H | 1 |
Aeschlimann, C; Cerny, T; Küpfer, A | 2 |
Alonso, JL; Díaz-Rubio, E; López, JA; Martín, M; Nieto, Y | 1 |
Koschuth, A; Possinger, K; Späth-Schwalbe, PE | 1 |
Foxall, PJ; Hartley, JM; Lapsley, M; Neild, GH; Nicholson, JK; Singer, JM; Souhami, RL | 1 |
Budd, GT; Gurm, HS | 1 |
Idle, JR; Küpfer, A | 1 |
Bokossa, A; Ogouassangni, A; Perra, A; Quere, M; Van Damme, W | 1 |
Sherratt, HS; Turnbull, DM | 1 |
De Vos, F; Pelgrims, J; Prové, A; Schrijvers, D; Van den Brande, J; Vermorken, JB | 1 |
7 review(s) available for methylene blue and Brain Disorders
Article | Year |
---|---|
A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature.
Topics: Brain Diseases; Child; Female; Humans; Ifosfamide; Methylene Blue; Neurotoxicity Syndromes; Sleepiness | 2022 |
Ifosfamide - History, efficacy, toxicity and encephalopathy.
Topics: Antineoplastic Agents; Brain Diseases; Cyclophosphamide; Humans; Ifosfamide; Methylene Blue | 2023 |
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation.
Topics: Animals; Brain Diseases; Humans; Low-Level Light Therapy; Methylene Blue; Mitochondria; Neuroprotection | 2020 |
Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Topics: Adult; Albumins; Antineoplastic Agents, Alkylating; Bilirubin; Brain Diseases; Cohort Studies; Enzyme Inhibitors; Female; Hemoglobins; Humans; Ifosfamide; Male; Methylene Blue; Middle Aged; Nervous System Diseases; Obesity; Retrospective Studies; Risk Factors; Sarcoma; Sex Factors | 2008 |
Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.
Topics: Adenoma; Brain Diseases; Citalopram; Drug Interactions; Enzyme Inhibitors; Female; Humans; Methylene Blue; Middle Aged; Parathyroid Neoplasms; Parathyroidectomy; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors | 2009 |
Evaluating risk factors for the development of ifosfamide encephalopathy.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antineoplastic Agents, Alkylating; Brain Diseases; Cohort Studies; Confusion; Creatinine; Female; Hallucinations; Humans; Hypoalbuminemia; Ifosfamide; Male; Methylene Blue; Middle Aged; Neoplasms; Odds Ratio; Prevalence; Retrospective Studies; Risk Factors | 2005 |
Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain Diseases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Methylene Blue; Middle Aged; Neoplasms; Treatment Outcome | 2000 |
30 other study(ies) available for methylene blue and Brain Disorders
Article | Year |
---|---|
Ifosfamide-induced Encephalopathy With Rapid Response to Thiamine: A Pediatric Case.
Topics: Antineoplastic Agents, Alkylating; Brain Diseases; Child; Cisplatin; Creatinine; Humans; Ifosfamide; Methylene Blue; Serum Albumin; Thiamine | 2022 |
Ifosfamide induced encephalopathy in a child with osteosarcoma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Diseases; Female; Humans; Ifosfamide; Methylene Blue; Neurotoxicity Syndromes; Osteosarcoma | 2021 |
Methylene blue and ifosfamide-induced encephalopathy: Myth or reality?
Topics: Aged; Antineoplastic Agents, Alkylating; Brain; Brain Diseases; Creatinine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Methylene Blue; Middle Aged; Morocco; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Ifosfamide-related encephalopathy with severe clinical presentations in children with cancer.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Diseases; Child; Female; Humans; Ifosfamide; Methylene Blue; Neoplasms | 2021 |
Laundry Blues: a case of methemoglobinemia with laundry detergent and Tylenol ingestion.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Bipolar Disorder; Brain Diseases; Detergents; Female; Ferrocyanides; Free Radical Scavengers; Humans; Indoles; Methemoglobinemia; Methylene Blue; Respiration, Artificial; Respiratory Insufficiency; Suicide, Attempted; Treatment Outcome; Young Adult | 2017 |
After Treatment with Methylene Blue is Effective against Delayed Encephalopathy after Acute Carbon Monoxide Poisoning.
Topics: Animals; Anti-Inflammatory Agents; Antidotes; Antioxidants; Apoptosis; Behavior, Animal; Brain Diseases; CA1 Region, Hippocampal; Carbon Monoxide Poisoning; Cognition; Disease Models, Animal; Inflammation Mediators; Interleukin-1beta; Male; Maze Learning; Methylene Blue; Mitochondria; Mitochondrial Dynamics; Neurons; Oxidative Stress; Rats, Sprague-Dawley; Spatial Learning; Time Factors; Tumor Necrosis Factor-alpha | 2018 |
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
Topics: Administration, Intravenous; Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Diseases; Child; Cytochrome P-450 CYP2B6; Female; Genetic Predisposition to Disease; Humans; Ifosfamide; Male; Methylene Blue; Neuroprotective Agents; Osteosarcoma; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Treatment Outcome | 2018 |
Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methylene Blue; Middle Aged; Rituximab; Thiamine | 2019 |
Green urine secondary to methylene blue.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Male; Methylene Blue; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Urine | 2014 |
Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Amyloidosis; Animals; Brain Diseases; Cerebral Cortex; CHO Cells; Cognition; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; Humans; Male; Maze Learning; Methylene Blue; Mice, Inbred C57BL; Mice, Transgenic; Proteolysis | 2014 |
The Use of Continuous Veno-Venous Hemodiafiltration in the Management of Ifosfamide-induced Encephalopathy: A Case Report.
Topics: Antineoplastic Agents, Alkylating; Brain Diseases; Child; Female; Hemodiafiltration; Humans; Ifosfamide; Methylene Blue; Neuroblastoma | 2016 |
Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy.
Topics: Aged; Brain Diseases; Coma; Critical Care; Enzyme Inhibitors; Glasgow Coma Scale; Humans; Male; Methylene Blue; Parathyroidectomy; Postoperative Complications; Radiography; Serotonin Syndrome; Urine | 2009 |
Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy.
Topics: Brain Diseases; Humans; Ifosfamide; Methylene Blue; Serotonin Syndrome | 2012 |
Early glucose and methylene blue are effective against unripe ackee apple (Blighia sapida) poisoning in mice.
Topics: Animals; Blighia; Brain Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Fruit; Glucose; Humans; Injections, Intraperitoneal; Male; Methylene Blue; Mice; Plant Poisoning; Random Allocation; Time Factors; Treatment Outcome | 2004 |
Cerebral formation in situ of S-carboxymethylcysteine after ifosfamide administration to mice: a further clue to the mechanism of ifosfamide encephalopathy.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain; Brain Diseases; Carbocysteine; Drug Interactions; Drug Therapy, Combination; Female; Glutamic Acid; Ifosfamide; Methylene Blue; Mice; Monoamine Oxidase Inhibitors; Serotonin | 2006 |
Intravenous Methylene Blue for Studying Fiber Degeneration in the Central Nervous System.
Topics: Brain; Brain Diseases; Central Nervous System; Coloring Agents; Humans; Methylene Blue; Staining and Labeling | 1948 |
Agglutination test for diagnosis of toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Agglutination Tests; Brain Diseases; Fluorescent Antibody Technique; Humans; Methylene Blue; Toxoplasmosis | 1983 |
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.
Topics: Administration, Oral; Adolescent; Antidotes; Bone Neoplasms; Brain Diseases; Drug Overdose; Female; Glutarates; Humans; Ifosfamide; Injections, Intravenous; Lung Neoplasms; Methylene Blue; Osteosarcoma; Premedication; Sarcosine | 1994 |
[Treatment of ifosfamide induced encephalopathy with methylene-blue].
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Diseases; Female; Humans; Ifosfamide; Methylene Blue; Peritoneal Neoplasms; Uterine Neoplasms | 1995 |
Methylene blue for ifosfamide-associated encephalopathy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Ifosfamide; Methylene Blue; Uterine Cervical Neoplasms | 1995 |
[Successful treatment with methylene blue of ifosfamide-induced central nervous system effects].
Topics: Antidotes; Antineoplastic Agents, Alkylating; Brain Diseases; Humans; Ifosfamide; Male; Methylene Blue; Middle Aged | 1996 |
Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.
Topics: Administration, Oral; Animals; Antidotes; Antineoplastic Agents, Alkylating; Brain Diseases; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Ifosfamide; Methylene Blue; Oxidation-Reduction; Rats | 1996 |
Ifosfamide encephalopathy and methylene-blue: a case report.
Topics: Brain Diseases; Female; Humans; Ifosfamide; Methylene Blue; Middle Aged | 1996 |
[Methylene blue in ifosfamide-induced encephalopathy].
Topics: Antineoplastic Agents, Alkylating; Brain Diseases; Female; Humans; Ifosfamide; Methylene Blue; Middle Aged | 1996 |
Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.
Topics: Alkylation; Animals; Antidotes; Antineoplastic Agents; Brain Diseases; Cattle; Ifosfamide; In Vitro Techniques; Liver; Male; Methylene Blue; Mice; Monoamine Oxidase Inhibitors; Perfusion; Rats; Rats, Wistar | 1996 |
Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Topics: Adult; Amino Acids; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Brain Diseases; Dicarboxylic Acids; Humans; Ifosfamide; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Kidney Medulla; Magnetic Resonance Spectroscopy; Mesna; Methylene Blue; Molecular Weight; Neoplasms; Protons; Retinol-Binding Proteins; Urinalysis | 1997 |
A 47-year-old man with leiomyosarcoma and altered mental status.
Topics: Brain Diseases; Fatal Outcome; Humans; Ifosfamide; Leiomyosarcoma; Male; Methylene Blue; Middle Aged; Neurobehavioral Manifestations; Physical Examination; Retroperitoneal Neoplasms | 1999 |
Methylene blue and fatal encephalopathy from ackee fruit poisoning.
Topics: Brain Diseases; Burkina Faso; Child, Preschool; Fruit; Humans; Hypoglycins; Methylene Blue | 1999 |
Methylene blue and fatal encephalopathy from ackee fruit poisoning.
Topics: Brain Diseases; Burkina Faso; Child; Child, Preschool; Fruit; Humans; Methylene Blue; Plant Poisoning | 1999 |
Methylene blue and fatal encephalopathy from ackee fruit poisoning.
Topics: Africa, Western; Brain Diseases; Child, Preschool; Fruit; Humans; Hypoglycins; Methylene Blue; Plant Poisoning | 1999 |